Close

Shop by Category

Top Brands*

  • Marco Pharma
  • MediHerb
  • Physica Energetics
  • Professional Health Products
  • Standard Process
  • Volcana Life
  • Xymogen
  • *You must have patient account to shop these brands

    Site Information

     Loading... Please wait...

    Hemp Oil | CBD

    Q: What is CBD?

    A: Cannabidiol (CBD) is a non-psychoactive, naturally occurring compound of industrial hemp. CBD belongs to a class of molecules called Cannabinoids. 

    Q: Is CBD safe?

    A: Unlike THC, CBD does not cause a high. Several studies suggest that CBD is well tolerated and safe even at higher doses. 

    Q: Why is CBD good for you?

    A: CBD has been shown to interact with the Endocannabinoid System (ECS) and to be involved in the activation of the immune system. We make no claim as to the usefulness of Cannabidiol for therapeutic treatments. We encourage you to conduct your own research. 

    Q: What is the right controlled serving size?

    A: The rule of thumb is to start with a low serving size or milligram intake and increase slowly until optimum effects are reached. 

    Q: What are the most effective delivery methods?

    A: The bioavailability of CBD varies greatly depending on the administration method. Studies have shown bioavailability of up to 40% when inhaled, and 6% when ingested. However, other studies suggest bioavailability with transdermal or oromucosal administration to be much higher. 

    Q: Is CBD legal?

    A: Hemp-derived CBD-rich dietary extracts are fully legal in all 50 states. The legality of CBD from hemp is based on a 2004 unanimous ruling by the Ninth Circuit Court of Appeals, which determined that the DEA “cannot regulate naturally-occurring THC not contained within or derived from marijuana, i.e., non-psychoactive hemp is not included in Schedule I. The DEA has no authority to regulate drugs that are not scheduled…”

    Cannabidiol (CBD) is a compound found in the cannabis sativa plant. CBD belongs to a class of molecules called cannabinoids.

    Cannabidiol targets the EndoCannabinoid System (ECS). The EndoCannabinoid System is a system within the body that controls the way the body reacts to normal physiological processes. This molecular signaling system controls how the human body experiences pain, stress, hunger, sleep, circadian rhythms, blood pressure, body temperature, bone density, fertility, intestinal fortitude, mood, metabolism, memory retention, and more.

    The EndoCannabinoid System produces naturally occurring cannabinoids, Anadamide and 2-AG(2-atachidonoylglycerol), which stimulates the body’s cannabinoid receptors, CB1 and CB2. It is these receptors that engage in “retrograde signaling,” a unique form of inter-cellular communication that inhibits immune response, reduces inflammation, relaxes musculature, lowers blood pressure, dilates bronchial passages, increases cerebral blood flow (a rush of thoughts) and normalizes over-stimulated nerves.

    Retrograde signaling serves as an inhibitory feedback mechanism that tells other neurotransmitters to slow down when they are firing too fast. Neurotransmitters are the body’s “firing” system; a chemical that sends signals from one cell to another resulting in activity, and over activity if they are firing too quickly.

    CBD stimulates the release of our natural endocannabinoids 2-AG and anandamide. CBD also inhibits the enzyme that metabolizes and destroys anandamide. By doing so, CBD enhances the body’s innate protective endocannabinoid response.

    CBD was isolated in 1963, lacks psychoactivity, and does not appear to bind to CB1 or CB2 receptors, but rather interacts with a multitude of various ion channels, enzymes, and other receptors that are felt to explain its potential analgesic, antiepileptic, anti-nausea, anti-emetic, anti-inflammatory, anxiolytic, anti-psychotic, and anti-ischemic properties. Its potential analgesic and anti-inflammatory effects are mediated by both cyclooxygenase and lipoxygenase inhibition, and its antiinflammatory effect is several hundred times more potent than aspirin in animal studies. CBD also has strong anti-oxidant actions, more potent than α-tocopherol and ascorbate, and has been shown to reduce NMDA, α-amino-3-hydroxyl-5-methyl-4-isoxazole-propionate, and kainate receptormediated neurotoxicities.

     

    Clinical studies and research papers

    Inflammation & Oxidative Stress

    Inflammation

    Diabetes

    Alzheimer’s

    Anxiety & Depression

    Headache & Migraine

    Cancer

    Cardiovascular System

    Addiction